Regeneron Pharmaceuticals Inc
XBER:RGO
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
R
|
Regeneron Pharmaceuticals Inc
XBER:RGO
|
US |
|
B
|
Best Buy Co Inc
F:BUY
|
US |
|
C
|
China Industrial Group Inc
OTC:CIND
|
US |
|
Isetan Mitsukoshi Holdings Ltd
OTC:IMHDY
|
JP |
|
T
|
Thermo Fisher Scientific Inc
SWB:TN8
|
US |
|
A
|
Air Products and Chemicals Inc
DUS:AP3
|
US |
|
F
|
Fresenius SE & Co KGaA
SWB:FRE
|
DE |
|
C
|
Compagnie de Saint Gobain SA
XHAM:GOB
|
FR |
|
F
|
FirstRand Ltd
JSE:FSR
|
ZA |
|
Tenaris SA
BMV:TS
|
LU |
|
I
|
IHI Corp
OTC:IHICF
|
JP |
|
D
|
Deutsche Post AG
XHAM:DPW
|
DE |
|
B
|
British American Tobacco PLC
LSE:0A76
|
UK |
|
P
|
PureTech Health PLC
OTC:PTCHF
|
US |
Wall St Price Targets
RGO Price Targets Summary
Regeneron Pharmaceuticals Inc
According to Wall Street analysts, the average 1-year price target for RGO is 159.61 EUR with a low forecast of 120.23 EUR and a high forecast of 200.18 EUR.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is RGO's stock price target?
Price Target
159.61
EUR
According to Wall Street analysts, the average 1-year price target for RGO is 159.61 EUR with a low forecast of 120.23 EUR and a high forecast of 200.18 EUR.
What is the Revenue forecast for Regeneron Pharmaceuticals Inc?
Projected CAGR
5%
Over the last 14 years, the compound annual growth rate for Revenue has been 28%. The projected CAGR for the next 8 years is 5%.
What is the Operating Income forecast for Regeneron Pharmaceuticals Inc?
Projected CAGR
12%
The compound annual growth rate for Operating Income over the next 8 years is 12%.
What is the Net Income forecast for Regeneron Pharmaceuticals Inc?
Projected CAGR
8%
The compound annual growth rate for Net Income over the next 8 years is 8%.
